AAF Sends FOIA to FDA on Approval of Chemical Abortion Drug

Advancing American Freedom, joined by twenty-nine other pro-life groups, sent a Freedom of Information Act (FOIA) request to the Food and Drug Administration (FDA) regarding their approval of the chemical abortion drug mifepristone in 2000, and the underreported incidents that followed the use of the drug.

“When the FDA approved mifepristone in 2000 there was underreporting of serious incidents for the women who used the drug,” said AAF General Counsel J. Marc Wheat. “The women whose health and safety were jeopardized by this drug deserve answers and accountability about the approval process for the chemical abortion drug.”